<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the relationship between PTEN gene expression and Akt phosphorylation (p-Akt) in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and to explore the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and the mechanism of high risk transformation to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: RT-PCR was used to detect the PTEN <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines K562 (as negative control) and Jurkat (as positive control) and 65 MDS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>Flow cytometry was used to detect p-Akt in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 and Jurkat cells and 30 MDS patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: (1) K562 cells present PTEN gene expression while Jurkat cells did not </plain></SENT>
<SENT sid="4" pm="."><plain>Of 65 MDS and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients, 27 (41.5%) expressed PTEN <z:chebi fb="2" ids="33699">mRNA</z:chebi>, being significantly lower than that in <z:mpath ids='MPATH_458'>normal</z:mpath> group (85.7%) (P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>(2) Jurkat cell showed high expression (86.9%) of p-Akt, while <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cell as negative control did not express </plain></SENT>
<SENT sid="6" pm="."><plain>P-Akt levels of 30 MDS patients were increased (1.35% - 58.23%), being much higher as compared with that of the <z:mpath ids='MPATH_458'>normal</z:mpath> contrast group (0.54% - 2.34%) (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, with the rate of blast cells increasing, the p-Akt level was rising up </plain></SENT>
<SENT sid="8" pm="."><plain>There is a positive correlation (r = 0.93, P &lt; 0.01) between the low expression rate of PTEN and the positive rate of p-Akt </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The loss of PTEN gene expression is one of the important factors of p-Akt high expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, moreover, it may speed up the progress of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or transformation to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
</text></document>